Heterogeneity of Risk Factors and Antibody Profiles in Epstein‐Barr Virus Genome–Positive and –Negative Hodgkin Lymphoma
Author(s) -
Ellen T. Chang,
Tongzhang Zheng,
Evelyne T. Lennette,
Edward G. Weir,
Michael J. Borowitz,
Risa B. Mann,
Donna Spiegelman,
Nancy Müeller
Publication year - 2004
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/420886
Subject(s) - nodular sclerosis , odds ratio , lymphoma , epstein–barr virus , immunology , virus , gammaherpesvirinae , antibody , medicine , etiology , antigen , herpesviridae , viral disease , hodgkin lymphoma
Hodgkin lymphoma (HL) tumors that contain the Epstein-Barr virus (EBV) genome may differ etiologically from EBV-negative HL tumors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom